Ledger.Open graph →
SEC Form D · filed October 17, 2023

Novastream Therapeutics Inc

Offering
$250K
Sold
$50K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DENVER, CO
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Thomas Kluz · Denver, CODirectorManuel Ornelas · Denver, COExec · DirectorMark Webb · Provo, UTDirectorJason Novak · Denver, CODirectorManuel Ornelas · Denver, COExec · DirectorMark Webb · Quincy, MADirectorJason Novak · Denver, CODirectorThomas Kluz · Denver, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗